Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Intersect ENT, Inc.

Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT Reports Third Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT Reports Second Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT to Report Second Quarter 2021 Financial Results on August 6
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT Reports First Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT to Participate at Upcoming Investor Conferences
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT Announces Appointment of New Vice President of Sales
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT Announces Date Change for First Quarter 2021 Financial Results Announcement
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Intersect ENT to Report First Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.